CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 19.14 USD 0.37%
Market Cap: 1.1B USD
Have any thoughts about
CareDx Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one CDNA stock under the Base Case scenario is 25.55 USD. Compared to the current market price of 19.14 USD, CareDx Inc is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CDNA Relative Value
Base Case
25.55 USD
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
60
vs Industry
70
Median 3Y
2.7
Median 5Y
3.8
Industry
7.2
Forward
2.8
More Details
18
P/E
P/E
Price to Earnings
18
vs History
4
vs Industry
7
Median 3Y
-5.9
Median 5Y
-11.4
Industry
23.2
Forward
31
More Details
39.6
P/OCF
P/OCF
Price to OCF
39.6
vs History
31
vs Industry
6
Median 3Y
-32.2
Median 5Y
-24.9
Industry
19.3
More Details
52.7
P/FCFE
P/FCFE
Price to FCFE
52.7
vs History
19
vs Industry
6
Median 3Y
-19.5
Median 5Y
-21.3
Industry
22.5
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
57
vs Industry
32
Median 3Y
2.4
Median 5Y
3.2
Industry
2.7
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
60
vs Industry
64
Median 3Y
1.8
Median 5Y
3
Industry
7.5
Forward
2.2
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
60
vs Industry
63
Median 3Y
2.7
Median 5Y
4.5
Industry
9.4
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
34
Median 3Y
-9.4
Median 5Y
-24.2
Industry
4.6
Forward
25.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
33
Median 3Y
-7.6
Median 5Y
-17.7
Industry
4.5
Forward
62.3
More Details
31
EV/OCF
EV/OCF
Enterprise Value to OCF
31
vs History
31
vs Industry
8
Median 3Y
-14.7
Median 5Y
-12.6
Industry
4.9
More Details
41.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
41.2
vs History
19
vs Industry
6
Median 3Y
-9.5
Median 5Y
-11.2
Industry
3.7
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
58
vs Industry
35
Median 3Y
2.4
Median 5Y
4.3
Industry
4.9
More Details

Multiples Across Competitors

CDNA Competitors Multiples
CareDx Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
CareDx Inc
NASDAQ:CDNA
1.1B USD 3.1 18 -29.2 -19.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 345 565.3 -163 239.4 -198 224.7 -195 962.7
US
Abbvie Inc
NYSE:ABBV
329.6B USD 5.7 79.2 15.1 22.4
US
Amgen Inc
NASDAQ:AMGN
157.1B USD 4.6 26.4 14.3 23.5
US
Gilead Sciences Inc
NASDAQ:GILD
134.8B USD 4.7 22.5 9.9 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.6B USD 10.3 -115.8 24.6 25.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 051.2 -523.4 -569.9 -554.7
AU
CSL Ltd
ASX:CSL
115.9B AUD 5 27.5 17 21.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56B USD 4 12.4 11 12.4
US
Seagen Inc
F:SGT
39.3B EUR 19.8 -60.6 -65.3 -58.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.1B USD 17.1 -148.7 -666.1 -333.8
P/S Multiple
Revenue Growth P/S to Growth
US
CareDx Inc
NASDAQ:CDNA
Average P/S: 3 122 517.3
3.1
14%
0.2
FR
Pharnext SCA
OTC:PNEXF
34 345 565.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 051.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4
4%
1
US
S
Seagen Inc
F:SGT
19.8
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.1
29%
0.6
P/E Multiple
Earnings Growth PEG
US
CareDx Inc
NASDAQ:CDNA
Average P/E: 31
18
15%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 239.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.4
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.4 N/A N/A
AU
CSL Ltd
ASX:CSL
27.5
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBITDA: 15.3
Negative Multiple: -29.2 		N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 224.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -569.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -666.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBIT: 19.8
Negative Multiple: -19.6 		N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 962.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.5
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -554.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -333.8 N/A N/A

See Also

Summary
CDNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDNA stock valuation using valuation multiples.
Wall Street Estimates
CDNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.